These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39408932)

  • 1. Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs.
    Alejo T; Toro-Córdova A; Fernández L; Rivero A; Stoian AM; Pérez L; Navarro V; Martínez-Oliván J; de Miguel D
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and lyophilization of mRNA-encapsulating lipid nanoparticles.
    Wang T; Yu T; Li W; Liu Q; Sung TC; Higuchi A
    Int J Pharm; 2024 Sep; 662():124514. PubMed ID: 39067550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures.
    Meulewaeter S; Nuytten G; Cheng MHY; De Smedt SC; Cullis PR; De Beer T; Lentacker I; Verbeke R
    J Control Release; 2023 May; 357():149-160. PubMed ID: 36958400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings.
    Fan Y; Rigas D; Kim LJ; Chang FP; Zang N; McKee K; Kemball CC; Yu Z; Winkler P; Su WC; Jessen P; Hura GL; Chen T; Koenig SG; Nagapudi K; Leung D; Yen CW
    J Control Release; 2024 Sep; 373():727-737. PubMed ID: 39059500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoprotectant optimization for enhanced stability and transfection efficiency of pDNA-loaded ionizable lipid nanoparticles.
    Athaydes Seabra Ferreira H; Ricardo Aluotto Scalzo Júnior S; Kelton Santos de Faria K; Henrique Costa Silva G; Túllio Rodrigues Alves M; Oliveira Lobo A; Pires Goulart Guimarães P
    Int J Pharm; 2024 Nov; 665():124696. PubMed ID: 39265853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids.
    Lamoot A; Lammens J; De Lombaerde E; Zhong Z; Gontsarik M; Chen Y; De Beer TRM; De Geest BG
    Biomater Sci; 2023 Jun; 11(12):4327-4334. PubMed ID: 37073472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine.
    Muramatsu H; Lam K; Bajusz C; Laczkó D; Karikó K; Schreiner P; Martin A; Lutwyche P; Heyes J; Pardi N
    Mol Ther; 2022 May; 30(5):1941-1951. PubMed ID: 35131437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization.
    Ball RL; Bajaj P; Whitehead KA
    Int J Nanomedicine; 2017; 12():305-315. PubMed ID: 28115848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines.
    Kim B; Hosn RR; Remba T; Yun D; Li N; Abraham W; Melo MB; Cortes M; Li B; Zhang Y; Dong Y; Irvine DJ
    J Control Release; 2023 Jan; 353():241-253. PubMed ID: 36414195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.
    Lopes C; Cristóvão J; Silvério V; Lino PR; Fonte P
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1381-1395. PubMed ID: 36223174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
    Schoenmaker L; Witzigmann D; Kulkarni JA; Verbeke R; Kersten G; Jiskoot W; Crommelin DJA
    Int J Pharm; 2021 May; 601():120586. PubMed ID: 33839230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
    Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying.
    Ogawa K; Aikawa O; Tagami T; Ito T; Tahara K; Kawakami S; Ozeki T
    Int J Pharm; 2024 Nov; 665():124632. PubMed ID: 39182740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses.
    Wan J; Wang Z; Wang L; Wu L; Zhang C; Zhou M; Fu ZF; Zhao L
    mBio; 2024 Jan; 15(1):e0177523. PubMed ID: 38078742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size.
    Shi R; Liu X; Wang Y; Pan M; Wang S; Shi L; Ni B
    Hum Vaccin Immunother; 2024 Dec; 20(1):2342592. PubMed ID: 38714327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying.
    AboulFotouh K; Southard B; Dao HM; Xu H; Moon C; Williams Iii RO; Cui Z
    Int J Pharm; 2024 Jan; 650():123688. PubMed ID: 38070660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Robust Freeze-Drying Process for Long-Term Stability of rVSV-SARS-CoV-2 Vaccine.
    Khan MDFH; Youssef M; Nesdoly S; Kamen AA
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Alcohol Dilution-Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability.
    Shirane D; Tanaka H; Sakurai Y; Taneichi S; Nakai Y; Tange K; Ishii I; Akita H
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation materials for RNA-lipid nanoparticles: lyophilization and targeted transfection.
    Wang T; Sung TC; Yu T; Lin HY; Chen YH; Zhu ZW; Gong J; Pan J; Higuchi A
    J Mater Chem B; 2023 Jun; 11(23):5083-5093. PubMed ID: 37221913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.